Verapamil Hydrochloride Injection, Solution
Product Images NDC 43066-031

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 43066-031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure of verapamil hydrochloride showing molecular connectivity including methoxy groups, cyano group, and hydrochloride salt.*
FDA Label Image

Representative Vial Label 43066-031-25 (Image 02)

Representative Vial Label 43066-031-25 (Image 02)
Label for Verapamil Hydrochloride Injection, USP, 5 mg/2 mL (2.5 mg/mL) intravenous solution. The label indicates a 2 mL single dose vial, manufactured by Caplin Steriles Limited and distributed by Baxter Healthcare Corporation, Deerfield, IL. It includes the NDC number 43066-031-01 and instructions to protect from light.*
FDA Label Image

Representative Carton 43066-031-25 Panel 1 Of 3 (Image 03)

Representative Carton 43066-031-25 Panel 1 Of 3 (Image 03)
Label for Verapamil Hydrochloride Injection, USP, 5 mg/2 mL (2.5 mg/mL) single-dose vials. The label indicates the product is for intravenous use only, labeled by Baxter Healthcare Corporation, and includes NDC 43086-031-25. It specifies storage instructions and light protection precautions.*
FDA Label Image

Representative Carton Label 43066-031-25 Panel 2 Of 3 (Image 04)

Representative Carton Label 43066-031-25 Panel 2 Of 3 (Image 04)
Label for Verapamil Hydrochloride Injection, USP 5 mg/2 mL (2.5 mg/mL) by Baxter Healthcare Corporation. The label indicates the product is for intravenous use only and contains 25 single-dose vials of 2 mL each. Manufacturer details show Cipla Limited, India, with distributor information for Baxter Healthcare Corporation, Deerfield, IL.*
FDA Label Image

Representative Carton 43066-031-25 Panel 3 Of 3 (Image 05)

FDA Label Image

Representative Vial 43066-035-05 (Image 06)

Representative Vial 43066-035-05 (Image 06)
Verapamil Hydrochloride Injection, USP 10 mg/4 mL (2.5 mg/mL) in a 4 mL single dose vial for intravenous use. The label shows the proprietary name, concentration, dosage form, route of administration, and is labeled Rx only. Manufactured by Caplin Steriles Limited and distributed by Baxter Healthcare Corporation. Includes storage and usage instructions and a National Drug Code (NDC) number.*
FDA Label Image

Representative Carton Label 43066-035-05 Panel 1 Of 2 (Image 07)

Representative Carton Label 43066-035-05 Panel 1 Of 2 (Image 07)
Label for Verapamil Hydrochloride Injection, USP 10 mg/4 mL (2.5 mg/mL) intravenous solution by Baxter Healthcare Corporation. The package contains 5 single-dose vials of 4 mL each. The label includes storage instructions and dosage details.*
FDA Label Image

Representative Carton 43066-035-05 Panel 2 Of 2 (Image 08)

Representative Carton 43066-035-05 Panel 2 Of 2 (Image 08)
Packaging label for Verapamil Hydrochloride Injection, USP, 10 mg/4 mL (2.5 mg/mL) intravenous solution. The label indicates 5 single-dose vials of 4 mL each. Manufactured and labeled by Baxter Healthcare Corporation with identification and regulatory text included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.